[1]
“Ensemble-Based Virtual Screening of Mycobacterium tuberculosis ClpC1 Inhibitors”, acbr, vol. 6, no. 3, pp. 503–516, Jun. 2022, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/acbr/article/view/14931